Skip to Content
scroll

EBR Systems Inc (EBR)

ASX.EBR $1.36

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

LEARN MORE

EBR $1.36

20 MINUTE DELAYED

TODAY

0.00 %

1 YEAR RETURN

0.00%

VOLUME

0

DIV YIELD

0%

PE RATIO

0.00

52 WEEK RANGE

0.65

1.52

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

1.36

Change

0.00 (0.00)

Bid / Ask

1.36 - 1.39

Volume

0

Turnover

0

Open

0.00

Day Range

1.35 - 1.41

VWAP

0.00

Prev Close

1.36

Last Trade

16/01 7:14am (AEST)

i

KEY INFORMATION
Sector

Shares Issued

NTA/Share

0.00

Last Dividend

0.00

Dividend Ex Date

0

Dividend Pay Date

0

i

BROKER CALLS

current

Mean

0.00

Target Price

0.00

i

CURRENT ()
Revenue

EBITDA

Profit

Earnings Per Share (EPS)

0

Dividend Per Share (DPS)

0

Yield %

0.00

Market Cap

0

Price to Earnings Ratio (P/E)

0

i

TARGET PRICE FORECAST

i

ESTIMATES ()
Revenue

0.00

EBITDA

0.00

Profit

0.00

Earnings Per Share (EPS)

0.00

Dividend Per Share (DPS)

0.00

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation ()

0.00
image description

Business Summary

EBR Systems, Inc. is a medical device company, which develops wireless cardiac pacing system for heart failure. The Company is focused on developing treatment of cardiac rhythm disease by providing physiologically effective stimulation through wireless cardiac pacing by using Wireless Stimulation Endocardially (WiSE) technology. Its WiSE technology is a wireless cardiac pacing system to eliminate the need for coronary sinus leads to stimulate the left ventricle in heart failure patients requiring Cardiac Resynchronization Therapy (CRT). It was developed to address the persistent limitations of current CRT systems and to provide a more customized, patient-specific solution. It is also designed for more flexibility in pacing site selection to customize therapy for the individual.

image description

Relevant suggested news and content from the site

image description

Only available to Members

Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing. Click here
Back to top